Nkarta, Inc. Common Stock (NKTX)
PHARMACEUTICAL PREPARATIONS
Nkarta, Inc. Common Stock (NKTX) is listed on Nasdaq, where it has traded since July 10, 2020.
- Listed On
- Nasdaq
- Listed Since
- July 10, 2020
- Employees
- 103
- Market Cap
- $91M
About Nkarta, Inc. Common Stock
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 131 institutions reported holding NKTX, with 59.3 million shares worth $167.9 million in aggregate. The largest reported holder was RA Capital Management, with 10.8 million shares worth $30.6 million. Of the 5 largest holders listed below, 1 added shares and 4 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| RA Capital Management | 10,805,129 | $31M | Unchanged |
| BlackRock | 6,300,212 | $18M | Added 39.74% |
| Nea Management Company | 3,568,781 | $10M | Unchanged |
| Samsara Biocapital | 3,507,666 | $10M | Unchanged |
| SR One Capital Management | 3,333,333 | $9M | Unchanged |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is NKTX?
Nkarta, Inc. Common Stock (NKTX) is listed on Nasdaq, where it has traded since July 10, 2020.
Who are the largest institutional holders of NKTX?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of NKTX were RA Capital Management, BlackRock and Nea Management Company.
How many institutions own NKTX?
131 institutions reported a position in NKTX for the quarter ended June 30, 2026, worth $167.9 million in total.
Did institutions buy or sell NKTX last quarter?
Of the 5 largest reported holders, 1 added shares and 4 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for NKTX.
Every reported institutional holder, plus insider and congressional trades in NKTX, on SentiSense.